Table 1 Characteristics of the study population
Variables | Total | PIM use | PIMC use |
|---|---|---|---|
Observations, n (%) | 5′637 | 4′616 (81.9) | 3′461 (61.3) |
Patients with additional medication prescriptions, n (%) | |||
 Pre-Hospitalization | 3′132 (55.6) | 2′610 (56.5) | 958 (27.7) |
 Hospitalization | 3′331 (59.1) | 2′924 (63.3) | 1′563 (45.2) |
 Post-Hospitalization | 2′467 (43.8) | 2′040 (44.2) | 958 (27,7) |
Sociodemographics, n (%) | |||
 Age group by male sex | |||
  65–69 years | 682 (26.0) | 516 (25.5) | 349 (18.7) |
  70–74 years | 665 (25.4) | 511 (25.2) | 424 (22.7) |
  75–79 years | 530 (20.2) | 408 (20.1) | 412 (22.1) |
  80+ years | 743 (28.4) | 592 (29.2) | 680 (36.5) |
 Age group by female sex | |||
  65–69 years | 709 (23.5) | 613 (23.7) | 357 (22.4) |
  70–74 years | 732 (24.3) | 631 (24.4) | 400 (25.1) |
  75–79 years | 620 (20.6) | 523 (20.2) | 345 (21.6) |
  80+ years | 956 (31.7) | 822 (31.7) | 494 (31.0) |
 Female sex | 3′017 (53.5) | 2′388 (56.3) | 1′865 (53.9) |
 French speaking region | 559 (9.9) | 461 (10.0) | 312 (9.0) |
Insurance variables, n (%) | |||
 Low deductible (300,500) | 5′015 (89.0) | 4′150 (89.9) | 3′191 (92.2) |
 Managed care | 2′065 (36.6) | 1′696 (36.7) | 1′212 (35.0) |
 Supplementary hospital insurance | 3′267 (58.0) | 2′636 (57.1) | 1′994 (57.6) |
 Diagnosis group, n (%) | |||
  Neoplasia | 484 (8.6) | 422 (9.1) | 255 (7.4) |
  Circulatory system | 904 (16.0) | 661 (14.3) | 693 (20.0) |
  Respiratory system | 118 (2.1) | 93 (2.0) | 80 (2.3) |
  Digestive system | 409 (7.3) | 348 (7.5) | 223 (6.4) |
  Musculoskeletal system and connective tissue | 1′068 (18.9) | 986 (21.4) | 674 (19.5) |
  Urogenital system | 267 (4.7) | 212 (4.6) | 131 (3.8) |
  Injuries, poisoning and certain other consequences | 274 (4.9) | 234 (5.1) | 170 (4.9) |
  Other diagnosis | 427 (7.6) | 325 (7.0) | 256 (7.4) |